Title
Molecular characterization of respiratory syncytial virus in children with repeated infections with subgroup B in the Philippines
Date Issued
24 August 2018
Access level
open access
Resource Type
journal article
Author(s)
Okamoto M.
Dapat C.P.
Sandagon A.M.D.
Batangan-Nacion L.P.
Lirio I.C.
Tamaki R.
Saito-Obata M.
Lupisan S.P.
Oshitani H.
Tohoku University
Publisher(s)
Oxford University Press
Abstract
Background. Human respiratory syncytial virus (RSV) is the leading cause of severe acute respiratory infection in infants and young children, which is characterized by repeated infections. However, the role of amino acid substitutions in repeated infections remains unclear. Hence, this study aimed to elucidate the genetic characteristics of RSV in children with repeated infections using molecular analyses of F and G genes. Methods. We conducted a cohort study of children younger than 5 years in the Philippines. We collected nasopharyngeal swabs from children with acute respiratory symptoms and compared F and G sequences between initial and subsequent RSV infections. Results. We examined 1802 children from May 2014 to January 2016 and collected 3471 samples. Repeated infections were observed in 25 children, including 4 with homologous RSV-B reinfections. Viruses from the 4 pairs of homologous reinfections had amino acid substitutions in the G protein mostly at O-glycosylation sites, whereas changes in the F protein were identified at antigenic sites V (L173S) and θ (Q209K), considered essential epitopes for the prefusion conformation of the F protein. Conclusions. Amino acid substitutions in G and F proteins of RSV-B might have led to antigenic changes, potentially contributing to homologous reinfections observed in this study.
Start page
1045
End page
1053
Volume
218
Issue
7
Language
English
OCDE Knowledge area
Pediatría Sistema respiratorio Enfermedades infecciosas
Scopus EID
2-s2.0-85049909041
PubMed ID
Source
Journal of Infectious Diseases
ISSN of the container
00221899
Sponsor(s)
Financial support. This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Japan Agency for Medical and Research and Development (AMED) (grant number JP18fm0108013); the Science and Technology Research Partnership for Sustainable Development from AMED and Japan International Cooperation Agency (grant number JP16jm0110001); and Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (grant number JP16H02642).
Sources of information: Directorio de Producción Científica Scopus